1 | main | 18,397 |
2 | aforementioned | 330 |
3 | above-mentioned | 276 |
4 | overarching | 85 |
5 | aforesaid | 43 |
6 | sino-nasal | 43 |
7 | maternofetal | 11 |
8 | most-used | 9 |
9 | recovery-focused | 9 |
10 | decades-long | 8 |
11 | no-observed | 8 |
12 | non-beany | 8 |
13 | above-noted | 6 |
14 | best-established | 6 |
15 | second-meal | 5 |
16 | electroacoustic | 4 |
17 | psnhdd | 4 |
18 | earlier-mentioned | 3 |
19 | nac-related | 3 |
20 | physician-cited | 3 |
21 | 5-f₂-isop | 2 |
22 | above-listed | 2 |
23 | angiogenesis-modulating | 2 |
24 | anti-tax | 2 |
25 | antierosive | 2 |
26 | cyp2c8-mediated | 2 |
27 | different-hemifield | 2 |
28 | do-your-best | 2 |
29 | drug-abuse | 2 |
30 | forssman | 2 |
31 | gsh-mvk | 2 |
32 | macrolevel | 2 |
33 | mid-medial | 2 |
34 | most-common | 2 |
35 | neuroexcitatory | 2 |
36 | number-one | 2 |
37 | proverbial | 2 |
38 | service-related | 2 |
39 | sumo-modified | 2 |
40 | super-ordinate | 2 |
41 | 1,3,5-cyclooctatriene | 1 |
42 | 1-benzoyl-3-pentyl | 1 |
43 | 10-12-fold | 1 |
44 | 2-arylbenzimidazole | 1 |
45 | 3-bromo-5-nitro | 1 |
46 | 3-o-ethyl-3-o-propyl | 1 |
47 | 5-bromo-3-nitro | 1 |
48 | 5-cm-long | 1 |
49 | 5-ring | 1 |
50 | 5alpha-reduced | 1 |
51 | 8-carbon | 1 |
52 | all-3',5'-linkage | 1 |
53 | all-s-trans | 1 |
54 | anti-markovnikov-type | 1 |
55 | antipharmaceutical | 1 |
56 | asbestos-fracturing | 1 |
57 | between-footwear | 1 |
58 | bisacetylated | 1 |
59 | carabrane-type | 1 |
60 | chondroïtin | 1 |
61 | chromone-ring | 1 |
62 | cis-3-ap | 1 |
63 | cis-3-ap-nh3 | 1 |
64 | clinician-centric | 1 |
65 | co2mnge | 1 |
66 | cost/unit | 1 |
67 | covariate.in | 1 |
68 | ctt-based | 1 |
69 | demon-assisted | 1 |
70 | dextro | 1 |
71 | didemethyl | 1 |
72 | difficult-to-explain | 1 |
73 | dying.the | 1 |
74 | eag-active | 1 |
75 | eap.primary | 1 |
76 | ebbinghaus-titchener | 1 |
77 | ema-recommended | 1 |
78 | endocytoscopic | 1 |
79 | extension-continuing | 1 |
80 | fe-o2 | 1 |
81 | first-known | 1 |
82 | footfall | 1 |
83 | gai-specific | 1 |
84 | gemo | 1 |
85 | germ/gene | 1 |
86 | germacrane | 1 |
87 | gsh-ca | 1 |
88 | hb-lipid | 1 |
89 | hgecog/fmri | 1 |
90 | hrqol-measure | 1 |
91 | hsp40-stimulated | 1 |
92 | icbt-based | 1 |
93 | incidence/adverse | 1 |
94 | indium-rich | 1 |
95 | isordered | 1 |
96 | italian-german | 1 |
97 | less/lesser | 1 |
98 | lipoxygenase-derived | 1 |
99 | lognormal-transformed | 1 |
100 | mac-assigned | 1 |
101 | magnesium-deficiency | 1 |
102 | methyl-erythritol-4-phosphate | 1 |
103 | mg12zny | 1 |
104 | milk-theft | 1 |
105 | monodesmethylated | 1 |
106 | more-frequently-cited | 1 |
107 | more-heavily | 1 |
108 | moroi-matsuoka-sugioka | 1 |
109 | multivoltine | 1 |
110 | myelographical | 1 |
111 | n-hy-droxy-ethyl | 1 |
112 | neuroemotional | 1 |
113 | non-antagonistic | 1 |
114 | non-zoonotic | 1 |
115 | nonchlorinated | 1 |
116 | nondifferentiable | 1 |
117 | nonvaginal | 1 |
118 | o-qm | 1 |
119 | oh-aromatic | 1 |
120 | opeartive | 1 |
121 | origin-of-life | 1 |
122 | phenyl-attached | 1 |
123 | pmf-derived | 1 |
124 | practice.primary | 1 |
125 | preferences.the | 1 |
126 | professionalism-assessing | 1 |
127 | prognosis- | 1 |
128 | project-developed | 1 |
129 | protechnology | 1 |
130 | protocol-prespecified | 1 |
131 | protozan | 1 |
132 | pyruvate-derived | 1 |
133 | ring-bound | 1 |
134 | robotic-related | 1 |
135 | sheath-associated | 1 |
136 | spirocarbamate | 1 |
137 | sterane-containing | 1 |
138 | suicide-risk | 1 |
139 | sumo3-modified | 1 |
140 | survival-analysis | 1 |
141 | themes-product | 1 |
142 | time/accuracy | 1 |
143 | titular | 1 |
144 | trans-3-ap-nh3 | 1 |
145 | trebouxia | 1 |
146 | triplet-state | 1 |
147 | weak/strong | 1 |
148 | γ-halogeno-α-methyl-substituted | 1 |
149 | δ-diketone-substituted | 1 |
1 | 1,3,5-cyclooctatriene | 1 |
2 | 1-benzoyl-3-pentyl | 1 |
3 | 10-12-fold | 1 |
4 | 2-arylbenzimidazole | 1 |
5 | 3-bromo-5-nitro | 1 |
6 | 3-o-ethyl-3-o-propyl | 1 |
7 | 5-bromo-3-nitro | 1 |
8 | 5-cm-long | 1 |
9 | 5-f₂-isop | 2 |
10 | 5-ring | 1 |
11 | 5alpha-reduced | 1 |
12 | 8-carbon | 1 |
13 | above-listed | 2 |
14 | above-mentioned | 276 |
15 | above-noted | 6 |
16 | aforementioned | 330 |
17 | aforesaid | 43 |
18 | all-3',5'-linkage | 1 |
19 | all-s-trans | 1 |
20 | angiogenesis-modulating | 2 |
21 | anti-markovnikov-type | 1 |
22 | anti-tax | 2 |
23 | antierosive | 2 |
24 | antipharmaceutical | 1 |
25 | asbestos-fracturing | 1 |
26 | best-established | 6 |
27 | between-footwear | 1 |
28 | bisacetylated | 1 |
29 | carabrane-type | 1 |
30 | chondroïtin | 1 |
31 | chromone-ring | 1 |
32 | cis-3-ap | 1 |
33 | cis-3-ap-nh3 | 1 |
34 | clinician-centric | 1 |
35 | co2mnge | 1 |
36 | cost/unit | 1 |
37 | covariate.in | 1 |
38 | ctt-based | 1 |
39 | cyp2c8-mediated | 2 |
40 | decades-long | 8 |
41 | demon-assisted | 1 |
42 | dextro | 1 |
43 | didemethyl | 1 |
44 | different-hemifield | 2 |
45 | difficult-to-explain | 1 |
46 | do-your-best | 2 |
47 | drug-abuse | 2 |
48 | dying.the | 1 |
49 | eag-active | 1 |
50 | eap.primary | 1 |
51 | earlier-mentioned | 3 |
52 | ebbinghaus-titchener | 1 |
53 | electroacoustic | 4 |
54 | ema-recommended | 1 |
55 | endocytoscopic | 1 |
56 | extension-continuing | 1 |
57 | fe-o2 | 1 |
58 | first-known | 1 |
59 | footfall | 1 |
60 | forssman | 2 |
61 | gai-specific | 1 |
62 | gemo | 1 |
63 | germ/gene | 1 |
64 | germacrane | 1 |
65 | gsh-ca | 1 |
66 | gsh-mvk | 2 |
67 | hb-lipid | 1 |
68 | hgecog/fmri | 1 |
69 | hrqol-measure | 1 |
70 | hsp40-stimulated | 1 |
71 | icbt-based | 1 |
72 | incidence/adverse | 1 |
73 | indium-rich | 1 |
74 | isordered | 1 |
75 | italian-german | 1 |
76 | less/lesser | 1 |
77 | lipoxygenase-derived | 1 |
78 | lognormal-transformed | 1 |
79 | mac-assigned | 1 |
80 | macrolevel | 2 |
81 | magnesium-deficiency | 1 |
82 | main | 18,397 |
83 | maternofetal | 11 |
84 | methyl-erythritol-4-phosphate | 1 |
85 | mg12zny | 1 |
86 | mid-medial | 2 |
87 | milk-theft | 1 |
88 | monodesmethylated | 1 |
89 | more-frequently-cited | 1 |
90 | more-heavily | 1 |
91 | moroi-matsuoka-sugioka | 1 |
92 | most-common | 2 |
93 | most-used | 9 |
94 | multivoltine | 1 |
95 | myelographical | 1 |
96 | n-hy-droxy-ethyl | 1 |
97 | nac-related | 3 |
98 | neuroemotional | 1 |
99 | neuroexcitatory | 2 |
100 | no-observed | 8 |
101 | non-antagonistic | 1 |
102 | non-beany | 8 |
103 | non-zoonotic | 1 |
104 | nonchlorinated | 1 |
105 | nondifferentiable | 1 |
106 | nonvaginal | 1 |
107 | number-one | 2 |
108 | o-qm | 1 |
109 | oh-aromatic | 1 |
110 | opeartive | 1 |
111 | origin-of-life | 1 |
112 | overarching | 85 |
113 | phenyl-attached | 1 |
114 | physician-cited | 3 |
115 | pmf-derived | 1 |
116 | practice.primary | 1 |
117 | preferences.the | 1 |
118 | professionalism-assessing | 1 |
119 | prognosis- | 1 |
120 | project-developed | 1 |
121 | protechnology | 1 |
122 | protocol-prespecified | 1 |
123 | protozan | 1 |
124 | proverbial | 2 |
125 | psnhdd | 4 |
126 | pyruvate-derived | 1 |
127 | recovery-focused | 9 |
128 | ring-bound | 1 |
129 | robotic-related | 1 |
130 | second-meal | 5 |
131 | service-related | 2 |
132 | sheath-associated | 1 |
133 | sino-nasal | 43 |
134 | spirocarbamate | 1 |
135 | sterane-containing | 1 |
136 | suicide-risk | 1 |
137 | sumo-modified | 2 |
138 | sumo3-modified | 1 |
139 | super-ordinate | 2 |
140 | survival-analysis | 1 |
141 | themes-product | 1 |
142 | time/accuracy | 1 |
143 | titular | 1 |
144 | trans-3-ap-nh3 | 1 |
145 | trebouxia | 1 |
146 | triplet-state | 1 |
147 | weak/strong | 1 |
148 | γ-halogeno-α-methyl-substituted | 1 |
149 | δ-diketone-substituted | 1 |
1 | prognosis- | 1 |
2 | fe-o2 | 1 |
3 | cis-3-ap-nh3 | 1 |
4 | trans-3-ap-nh3 | 1 |
5 | gsh-ca | 1 |
6 | trebouxia | 1 |
7 | moroi-matsuoka-sugioka | 1 |
8 | gai-specific | 1 |
9 | endocytoscopic | 1 |
10 | clinician-centric | 1 |
11 | oh-aromatic | 1 |
12 | non-zoonotic | 1 |
13 | non-antagonistic | 1 |
14 | electroacoustic | 4 |
15 | psnhdd | 4 |
16 | 5alpha-reduced | 1 |
17 | ema-recommended | 1 |
18 | phenyl-attached | 1 |
19 | best-established | 6 |
20 | protocol-prespecified | 1 |
21 | sumo3-modified | 1 |
22 | sumo-modified | 2 |
23 | lognormal-transformed | 1 |
24 | mac-assigned | 1 |
25 | above-mentioned | 276 |
26 | earlier-mentioned | 3 |
27 | aforementioned | 330 |
28 | project-developed | 1 |
29 | isordered | 1 |
30 | icbt-based | 1 |
31 | ctt-based | 1 |
32 | most-used | 9 |
33 | recovery-focused | 9 |
34 | sheath-associated | 1 |
35 | cyp2c8-mediated | 2 |
36 | nac-related | 3 |
37 | robotic-related | 1 |
38 | service-related | 2 |
39 | hsp40-stimulated | 1 |
40 | monodesmethylated | 1 |
41 | bisacetylated | 1 |
42 | nonchlorinated | 1 |
43 | physician-cited | 3 |
44 | more-frequently-cited | 1 |
45 | above-noted | 6 |
46 | above-listed | 2 |
47 | demon-assisted | 1 |
48 | δ-diketone-substituted | 1 |
49 | γ-halogeno-α-methyl-substituted | 1 |
50 | lipoxygenase-derived | 1 |
51 | pyruvate-derived | 1 |
52 | pmf-derived | 1 |
53 | no-observed | 8 |
54 | aforesaid | 43 |
55 | hb-lipid | 1 |
56 | different-hemifield | 2 |
57 | 10-12-fold | 1 |
58 | ring-bound | 1 |
59 | origin-of-life | 1 |
60 | all-3',5'-linkage | 1 |
61 | co2mnge | 1 |
62 | dying.the | 1 |
63 | preferences.the | 1 |
64 | nondifferentiable | 1 |
65 | 2-arylbenzimidazole | 1 |
66 | germacrane | 1 |
67 | germ/gene | 1 |
68 | 1,3,5-cyclooctatriene | 1 |
69 | multivoltine | 1 |
70 | number-one | 2 |
71 | carabrane-type | 1 |
72 | anti-markovnikov-type | 1 |
73 | hrqol-measure | 1 |
74 | incidence/adverse | 1 |
75 | drug-abuse | 2 |
76 | methyl-erythritol-4-phosphate | 1 |
77 | spirocarbamate | 1 |
78 | super-ordinate | 2 |
79 | triplet-state | 1 |
80 | antierosive | 2 |
81 | eag-active | 1 |
82 | opeartive | 1 |
83 | overarching | 85 |
84 | sterane-containing | 1 |
85 | 5-ring | 1 |
86 | chromone-ring | 1 |
87 | asbestos-fracturing | 1 |
88 | professionalism-assessing | 1 |
89 | angiogenesis-modulating | 2 |
90 | extension-continuing | 1 |
91 | 5-cm-long | 1 |
92 | decades-long | 8 |
93 | weak/strong | 1 |
94 | indium-rich | 1 |
95 | hgecog/fmri | 1 |
96 | suicide-risk | 1 |
97 | gsh-mvk | 2 |
98 | myelographical | 1 |
99 | antipharmaceutical | 1 |
100 | second-meal | 5 |
101 | proverbial | 2 |
102 | mid-medial | 2 |
103 | nonvaginal | 1 |
104 | neuroemotional | 1 |
105 | sino-nasal | 43 |
106 | maternofetal | 11 |
107 | macrolevel | 2 |
108 | footfall | 1 |
109 | n-hy-droxy-ethyl | 1 |
110 | didemethyl | 1 |
111 | 3-o-ethyl-3-o-propyl | 1 |
112 | 1-benzoyl-3-pentyl | 1 |
113 | o-qm | 1 |
114 | italian-german | 1 |
115 | forssman | 2 |
116 | protozan | 1 |
117 | covariate.in | 1 |
118 | difficult-to-explain | 1 |
119 | main | 18,397 |
120 | chondroïtin | 1 |
121 | 8-carbon | 1 |
122 | most-common | 2 |
123 | first-known | 1 |
124 | gemo | 1 |
125 | 5-bromo-3-nitro | 1 |
126 | 3-bromo-5-nitro | 1 |
127 | dextro | 1 |
128 | cis-3-ap | 1 |
129 | 5-f₂-isop | 2 |
130 | between-footwear | 1 |
131 | titular | 1 |
132 | ebbinghaus-titchener | 1 |
133 | less/lesser | 1 |
134 | survival-analysis | 1 |
135 | all-s-trans | 1 |
136 | themes-product | 1 |
137 | milk-theft | 1 |
138 | cost/unit | 1 |
139 | do-your-best | 2 |
140 | anti-tax | 2 |
141 | time/accuracy | 1 |
142 | magnesium-deficiency | 1 |
143 | protechnology | 1 |
144 | more-heavily | 1 |
145 | non-beany | 8 |
146 | mg12zny | 1 |
147 | practice.primary | 1 |
148 | eap.primary | 1 |
149 | neuroexcitatory | 2 |